Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Our reseach centers on the development of accurate neurophysiological diagnostic tests (biomarkers) in early stage Parkinson’s disease. This project is led by Dr Chrystalina Antoniades and Professor Chris Kennard and is funded by the Wellcome trust, National Institute for Health Research Oxford Biomedical Research Centre and DeNDRoN (dementias and neurodegenerative diseases research network).